Upcoming Events
Search Result For "Gene".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to a...
Celebrating a Decade of Uniting the NK Cell Therapy Community! As the NK community remains determined as ever to prove the advantages of NK cell...
The 20th International Dead Sea Symposium, IDSS Innovations in Cardiac Arrhythmias and Heart Failure
The International Dead Sea Symposium (IDSS) on Cardiac Arrhythmias and Heart Failure has been held in Israel since 1992. Their mission is to make I...
As the cell and gene therapy (CGT) pipeline matures and new, exciting technologies scale into the clinic, the success of delivering the growing num...
In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements ...
19th World Congress on Controversies in Neurology (CONy), March 20-22, 2025 in Prague Czech Republic
CONy is an annual meeting that offers a unique platform for global experts to debate and discuss the most pressing and controversial issues in neur...
Welcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene th...
The Regenerative Agriculture Summit North America 2025 your opportunity to help shape a sustainable future for our industry and our planet. Through...
With the plasmid DNA manufacturing market set to rise to $39.3Bn by 2033, and the demand for advanced therapies continuing to surge as gene therapy...
The second Mayo Clinic Advanced Surgical Technologies and Robotics symposium provides updates on many surgical and medical disciplines, with a focu...
The 4th Annual Mayo Clinic Specialty Updates for the Generalist Team 2025 at the Margaritaville Resort Orlando is a three-day continuing medical ed...
The inherent heterogeneity of cancer - both inter-patient and intra-tumoral – remains a significant challenge in cancer modeling. With only 5% of...